Glucose uptake during centrally induced stress is insulin independent and enhanced by adrenergic blockade

Journal of Applied Physiology

Volumn 87, Issue 2, 1999, Pages 722-731

  Lekas, Michael C ^a   Fisher, Simon J ^a   El Bahrani, Ban ^a   Van Delangeryt, Mayliza ^a   Vranic, Mladen ^a,b   Shi, Z Qing ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Glucose clearance; Glucose production; Pancreatic clamp; Stress; adrenergic blockade; adrenergic blockade

Indexed keywords

ADRENALIN; BETA ADRENERGIC RECEPTOR; CARBACHOL; GLUCAGON; GLUCOSE; INSULIN; LACTIC ACID; NORADRENALIN; PHENTOLAMINE; PROPRANOLOL; SOMATOSTATIN;

ADRENERGIC RECEPTOR BLOCKING; ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; GLYCOGENOLYSIS; LIPOLYSIS; MALE; NONHUMAN; PRIORITY JOURNAL; STRESS;

EID: 0032817318     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.1999.87.2.722     Document Type: Article

References (60)

1. Avegaro, A., G. Toffolo, A. Valerio, and C. Cobelli. Epinephrine exerts opposite effects on peripheral glucose disposal and glucosestimulated insulin secretion. Diabetes 45: 1373-1378, 1996.
2. Baron, A. D., H. Steinberg, G. Brechtel, and A. Johnson. Skeletal muscle blood flow independently modulates insulin-mediated glucose uptake. Am. J. Physiol. 266 (Endocrinol. Metab. 29): E248-E253, 1994.
3. Baron, A. D., P. Wallace, and J. M. Olefsky. In vivo regulation of non-insulin-mediated and insulin-mediated glucose uptake by epinephrine. J. Clin. Endocrinol. Metab. 64: 409-415, 1987.
4. Best, J. B., and J. B. Halter. Blood pressure and norepinephrine spillover during propranolol infusion in humans. Am. J. Physiol. 248 (Regulatory Integrative Comp. Physiol. 17): R400-R406, 1985.
5. Bihler, I., P. C. Sawh, and I. G. Sloan. Dual effect of adrenalin on sugar transport in rat diaphragm muscle. Biochim. Biophys. Acta 510: 349-360, 1978.
6. Blaak, E. E., M. A. Van Baak, G. J. Kemerink, M. T. W. Pakbiers, G. A. K. Heidendal, and W. H. M. Saris. Beta-adrenergic stimulation of energy expenditure and forearm skeletal muscle metabolism in lean and obese men. Am. J. Physiol. 267 (Endocrinol. Metab. 30): E306-E315, 1994.
7. Boden, G., F. Jadali, J. White, Y. Liang, M. Mozzoli, X. Chen, E. Coleman, and C. Smith. Effects of fat on insulin-stimulated carbohydrate metabolism in normal men. J. Clin. Invest. 88: 960-966, 1991.
8. Brandi, L. S., D. Santoro, A. Natali, F. Altomonte, S. Baldi, S. Frascerra, and E. Ferrannini. Insulin resistance of stress: sites and mechanisms. Clin. Sci. (Colch.) 85: 525-535, 1993.
9. Brown, M. R., L. A. Fisher, J. Speiss, C. Rivier, J. Rivier, and W. Vale. Corticotrophin-releasing factor: actions on the sympathetic nervous system and metabolism. Endocrinology 111: 928-931, 1982.
10. Brown, M. R., J. Rivier, and W. Vale. Somatostatin: central nervous system's action on glucoregulation. Endocrinology 104: 1709-1715, 1979.
11. Cherrington, A. D., J. L. Chiasson, J. E. Liljenquist, A. S. Jennings, U. Keller, and W. W. Lacy. The role of insulin and glucagon in the regulation of basal glucose production in the postabsorptive dog. J. Clin. Invest. 58: 14071418, 1976.
12. Exton, J. H., F. D. Assimocopoulos-Jeannet, P. F. Blackmore, A. D. Cherrington, and T. M. Chan. Mechanisms of catecholamine action on liver carbohydrate metabolism. Adv. Cyclic Nucleotide Res. 9: 441-452, 1978.
13. Finegood, D. T., and R. N. Bergman. Optimal segments: a method for smoothing tracer data to calculate metabolic fluxes. Am. J. Physiol. 244 (Endocrinol. Metab. 7): E472-E479, 1983.
14. Fisher, S., M. Lekas, Z. Q. Shi, D. Bilinski, G. Carvalho, A. Giacca, and M. Vranic. Insulin-independent acute restoration of euglycemia normalizes the impaired glucose clearance during exercise in diabetic dogs. Diabetes 46: 1805-1812, 1997.
15. Giacca, A., R. Gupta, S. Efendic, K. Hall, A. Skottner, L. Lickley, and M. Vranic. Differential effects of IGFI and insulin on glucoregulation and fat metabolism in depancreatized dogs. Diabetes 39: 340-347, 1990.
16. Gray, D. E., H. L. A. Lickley, and M. Vranic. Physiologic effects of epinephrine on glucose turnover and plasma free fatty acid concentrations mediated independently of glucagon. Diabetes 29: 600-609, 1980.
17. Hargrove, D. M., G. J. Bagby, C. H. Lang, and J. J. Spitzer. Adrenergic blockade prevents endotoxin-induced increases in glucose metabolism. Am. J. Physiol. 255 (Endocrinol. Metab. 18): E629-E635, 1988.
18. 63Ni as tracer. Anal. Biochem. 36: 105-113, 1970.
19. Hoffman, B. B., and R. J. Lefkowitz. Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In: Goodman & Gilman's The Pharmacological Basis of Therapeutics (9th ed.), edited by J. G. Hardman, L. E. Limbird, and A. G. Gilman. New York: McGraw-Hill, 1996, chapt. 10, p. 199-248.
20. Hourani, H., D. B. Lacy, T. M. Nammour, N. N. Abumrad, and J. A. Morris. Differential effects of alpha and beta adrenergic blockade on glucose and lactate metabolism during acute stress. J. Trauma 30: 1116-1124, 1995.
21. Iguchi, A., M. Gotoh, H. Matsunaga, A. Yatomi, A. Honmura, M. Yanase, and N. Sakamoto. Mechanism of central hyperglycemic effect of cholinergic agonists in fasted rats. Am. J. Physiol. 251 (Endocrinol. Metab. 14): E431-E437, 1986.
22. Koerker, D. J., and J. B. Halter. Glucoregulation during insulin and glucagon deficiency: role of catecholamines. Am. J. Physiol. 243 (Endocrinol. Metab. 6): E225-E233, 1982.
23. Lang, C. H. Sepsis-induced insulin resistance in rats is mediated by a beta-adrenergic mechanism. Am. J. Physiol. 263 (Endocrinol. Metab. 26): E703-E711, 1992.
24. Lloyd, B., J. Burrin, P. Smythe, and K. G. M. M. Alberti. Enzymic fluorometric continuous-flow assays for blood glucose, lactate, pyruvate, alanine, glycerol, and 3-OH-butyrate. Clin. Chem. 24: 1724-1729, 1978.
25. Lum, B. K. B., Y. S. Lau, R. Buesa, R. H. Lockwood, and S. H. Kuo. Studies on the hyperglycemia and hepatic glycogenolysis produced by alpha and beta adrenergic agonists in the cat. Life Sci. 26: 1195-1202, 1980.
26. Lupien, J. R., M. F. Hirshman, and E. S. Horton. Effects of norepinephrine infusion on in vivo insulin sensitivity and responsiveness. Am. J. Physiol. 259 (Endocrinol. Metab. 22): E210-E215, 1990.
27. Marette, A., and L. Bukowiecki. Stimulation of glucose transport by insulin and norepinephrine in isolated rat brown adipocytes. Am. J. Physiol. 257 (Cell Physiol. 26): C714-C721, 1989.
28. McGuinness, O. P., T. Fugiwara, S. Murrell, D. Bracy, D. Neal, D. O'Connor, and A. D. Cherrington. Impact of chronic stress hormone infusion on hepatic carbohydrate metabolism in the conscious dog. Am. J. Physiol. 265 (Endocrinal. Metab. 28): E314-E322, 1993.
29. Miles, P., D. T. Finegood, L. Lickley, and M. Vranic. Regulation of glucose turnover at the onset of exercise in dogs. J. Appl. Physiol. 72: 24872494, 1992.
30. Miles, P. D. G., K. Yamatani, M. R. Brown, H. L. A. Lickley, and M. Vranic. Intracerebroventricular administration of somatostatin octapeptide counteracts the hormonal and metabolic responses to stress in normal and diabetic dogs. Metabolism 43: 1134-1143, 1994.
31. Miles, P. D. G., K. Yamatani, H. L. A. Lickley, and M. Vranic. Mechanism of glucoregulatory responses to stress and their deficiency in diabetes. Proc. Natl. Acad. Sci. USA 88: 1296-1300, 1991.
32. Piatti, P. M., L. D. Monti, A. E. Pacchioni, and G. Pozza. Forearm insulin- and non-insulin-mediated glucose uptake and muscle metabolism in man: role of free fatty acids and blood glucose levels. Metabolism 40: 926-933, 1991.
33. Radziuk, J., and H. L. A. Lickley. The metabolic clearance of glucose: measurement and meaning. Diabetologia 28: 315-322, 1985.
34. Randle, P. J., P. B. Garland, C. N. Hales, and E. A. Newsholme. The glucose-fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1: 785-789, 1963.
35. Richter, E. A., N. B. Ruderman, and H. Galbo. Alpha and beta adrenergic effects on metabolism in contracting, perfused muscle. Acta Physiol. Scand. 116: 215-222, 1982.
36. Rizza, R. A., M. Haymond, P. Cryer, and J. Gerich. Differential effects of epinephrine on glucose production and disposal in man. Am. J. Physiol. 237 (Endocrinol. Metab. Gastrointest. Physiol. 6): E356-E362, 1979.
37. Rizza, R. A., M. W. Raymond, J. M. Miles, C. A. Verdonk, P. E. Cryer, and J. E. Gerich. Effect of alpha-adrenergic stimulation and its blockade on glucose turnover in man. Am. J. Physiol. 238 (Endocrinol. Metab. 1): E467-E472, 1980.
38. Rosen, S. G., E. Clutter, S. D. Shah, J. P. Miller, D. M. Bier, and P. E. Cryer. Direct alpha-adrenergic stimulation of hepatic glucose production in human subjects. Am. J. Physiol. 245 (Endocrinol. Metab. 8): E616-E626, 1983.
39. Sherline, P., A. Lynch, and W. H. Glinsmann. Cyclic cAMP and adrenergic receptor control of rat liver glycogen metabolism. Endocrinology 91: 680-690, 1972.
40. Shi, Z. Q., A. Giacca, K. Yamatani, S. Fisher, L. Lickley, and M. Vranic. Effects of subbasal insulin infusion on resting and exercise-induced glucose uptake in depancreatized dogs. Am. J. Physiol. 264 (Endocrinol, Metab. 27): E334-E341, 1993.
41. Shi, Z. Q., D. H. Wasserman, and M. Vranic. Metabolic implications of exercise and physical fitness in physiology and diabetes. In: Ellenberg and Rifkin's Diabetes Mellitus (5th ed.), edited by D. Porte, Jr., and R. Sherwin. Norwalk, CT: Appleton and Lange, 1997, p. 653-687.
42. Sigal, R. J., S. Fisher, J. B. Halter, M. Vranic, and E. B. Marliss. The roles of catecholamines in glucoregulation in intense exercise as defined by the islet cell clamp technique. Diabetes 45: 148-156, 1996.
43. Sigal, R. J., C. Purdon, D. Bilinski, M. Vranic, J. B. Halter, and E. B. Marliss. Glucoregulation during and after intense exercise: effects of beta blockade. J. Clin. Endocrinol. Metab. 78: 359-366, 1994.
44. Silverberg, A. B., S. D. Shah, M. W. Raymond, and P. E. Cryer. Norepinephrine: hormone and neurotransmitter in man. Am. J. Physiol. 234 (Endocrinol. Metab. Gastrointest. Physiol. 3): E252-E256, 1978.
45. Sole, M. J., and M. N. Hussein. A simple specific radioenzymatic assay for the simultaneous measurement of picogram quantities of norepinephrine, epinephrine, and dopamine in plasma tissues. Biochem. Med. 18: 301-307, 1977.
46. Steele, R., J. S. Wall, R. C. deBodo, and N. Altszuler. Measurement of size and turnover rate of body glucose pool by isotope dilution method. Am. J. Physiol. 187: 15-24, 1956.
47. Stevenson, R. W., K. E. Steiner, C. C. Connolly, H. Fuchs, K. G. M. M. Alberti, P. E. Williams, and A. D. Cherrington. Dose-related effects of epinephrine on glucose production in conscious dogs. Am. J. Physiol. 260 (Endocrinol. Metab. 23): E363-E370, 1991.
48. Stevenson, R. W., K. E. Steiner, M. A. Davis, G. K. Hendrick, P. E. Williams, W. W. Lacy, L. Brown, P. Donahue, D. B. Lacy, and A. D. Cherrington. Similar dose responsiveness of hepatic glycogenolysis, and gluconeogenesis to glucagon in vivo. Diabetes 36: 382-389, 1987.
49. Sudo, M., Y. Minokoshi, and T. Shimazu. Ventromedial hypothalamic stimulation enhances peripheral glucose uptake in anesthetized rats. Am. J. Physiol. 261 (Endocrinol. Metab. 24): E298-E303, 1991.
50. Tarborsky, G. J., Jr., and D. Porte, Jr. Stress-induced hyperglycemia and its relation to diabetes mellitus. In: Stress: Neurobiology and Neuroendocrinology, edited by M. Brown, G. F. Koob, and C. Rivier. New York: Dekker, 1990, chapt. 24, p. 519-548.
51. Thiebaud, D., R. A. DeFronzo, E. Jacot, A. Golay, K. Acheson, E. Maeder, E. Jecquier, and J. P. Felber. Effect of long chain triglyceride infusion on glucose metabolism in man. Metabolism 31: 1128-1136, 1982.
52. Vranic, M., C. Gauthier, D. Bilinski, D. Wasserman, K. M. A. El Tayeb, G. J. Hetenyi, and H. L. A. Lickley. Catecholamine responses and their interactions with other glucoregulatory hormones. Am. J. Physiol. 247 (Endocrinol. Metab. 10): E145-E156, 1984.
53. Wasserman, D. H., H. L. A. Lickley, and M. Vranic. Interactions between glucagon and other counterregulatory hormones during normoglycemic and hypoglycemic exercise. J. Clin. Invest. 74: 1404-1413, 1984.
54. Wasserman, D. H., H. L. A. Lickley, and M. Vranic. Role of beta-adrenergic mechanisms during exercise in poorly controlled insulin-deficient diabetes. J. Appl. Physiol. 59: 1282-1289, 1985.
55. Weiss, B., and R. P. Maickel. Sympathetic nervous control of adipose tissue lipolysis. Int. J. Neuropharmacol. 7: 395-403, 1968.
56. Werther, G. A., S. Joffe, R. Artal, and M. A. Sperling. Physiological insulin action is opposed by beta-adrenergic mechanisms in dogs. Am. J. Physiol. 255 (Endocrinol. Metab. 18): E33-E40, 1988.
57. Wolfe, R. R., M. J. Durkot, and M. H. Wolfe. Investigation of kinetics of integrated metabolic response to adrenergic blockade in conscious dogs. Am. J. Physiol. 241 (Endocrinol. Metab. 4): E385-E395, 1981.
58. Yamatani, K., A. Shi, A. Giacca, R. Gupta, S. Fisher, L. Lickley, and M. Vranic. Role of FFA-glucose cycle in glucoregulation during exercise in total absence of insulin. Am. J. Physiol. 263 (Endocrinol. Metab. 26): E646-E653, 1992.
59. Yorek, M. A., G. A. Rufo, and P. D. Ray. Gluconeogenesis in rabbit liver. III. The influences of glucagon, epinephrine and alpha- and beta-adrenergic agents on gluconeogenesis in isolated hepatocytes. Biochem. Biophys. Acta 632: 517-526, 1980.
60. Young, D. A., H. Wallberg-Henriksson, J. Cranshaw, M. Chen, and J. O. Holloszy. Effects of catecholamines on glucose uptake and glycogenolysis in rat skeletal muscle. Am. J. Physiol. 248 (Cell Physiol. 17): C406-C409, 1985.